Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Imaging assessment of bioresorbable vascular scaffolds.
Sotomi Y, Suwannasom P, Tenekecioglu E, Collet C, Nakatani S, Okamura T, Muramatsu T, Ishibashi Y, Tateishi H, Miyazaki Y, Asano T, Katagiri Y, von Zur Muehlen C, Tanabe K, Kozuma K, Ozaki Y, Serruys PW, Onuma Y. Sotomi Y, et al. Among authors: suwannasom p. Cardiovasc Interv Ther. 2018 Jan;33(1):11-22. doi: 10.1007/s12928-017-0486-5. Epub 2017 Aug 1. Cardiovasc Interv Ther. 2018. PMID: 28766253 Review.
Darapladib for the treatment of cardiovascular disease.
Campos CM, Suwannasom P, Koenig W, Serruys PW, Garcia-Garcia HM. Campos CM, et al. Among authors: suwannasom p. Expert Rev Cardiovasc Ther. 2015 Jan;13(1):33-48. doi: 10.1586/14779072.2015.986466. Expert Rev Cardiovasc Ther. 2015. PMID: 25521799 Review.
Anatomic characteristics and clinical implications of angiographic coronary thrombus: insights from a patient-level pooled analysis of SYNTAX, RESOLUTE, and LEADERS Trials.
Campos CM, Costa F, Garcia-Garcia HM, Bourantas C, Suwannasom P, Valgimigli M, Morel MA, Windecker S, Serruys PW. Campos CM, et al. Among authors: suwannasom p. Circ Cardiovasc Interv. 2015 Apr;8(4):e002279. doi: 10.1161/CIRCINTERVENTIONS.114.002279. Circ Cardiovasc Interv. 2015. PMID: 25825008 Free article. Clinical Trial.
Snowshoe Versus Ice Skate for Scaffolding of Disrupted Vessel Wall.
Serruys PW, Suwannasom P, Nakatani S, Onuma Y. Serruys PW, et al. Among authors: suwannasom p. JACC Cardiovasc Interv. 2015 Jun;8(7):910-3. doi: 10.1016/j.jcin.2015.04.005. JACC Cardiovasc Interv. 2015. PMID: 26088509 Free article. No abstract available.
Incidence and Potential Mechanism(s) of Post-Procedural Rise of Cardiac Biomarker in Patients With Coronary Artery Narrowing After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold or Everolimus-Eluting Metallic Stent.
Ishibashi Y, Muramatsu T, Nakatani S, Sotomi Y, Suwannasom P, Grundeken MJ, Cho YK, Garcia-Garcia HM, van Boven AJ, Piek JJ, Sabaté M, Helqvist S, Baumbach A, McClean D, de Sousa Almeida M, Wasungu L, Miquel-Hebert K, Dudek D, Chevalier B, Onuma Y, Serruys PW. Ishibashi Y, et al. Among authors: suwannasom p. JACC Cardiovasc Interv. 2015 Jul;8(8):1053-1063. doi: 10.1016/j.jcin.2015.06.001. JACC Cardiovasc Interv. 2015. PMID: 26205444 Free article. Clinical Trial.
Fate of Bioresorbable Vascular Scaffold Metallic Radio-Opaque Markers at the Site of Implantation After Bioresorption.
Suwannasom P, Onuma Y, Campos CM, Nakatani S, Ishibashi Y, Tateishi H, Grundeken MJ, Stanetic B, Nieman K, Jonker H, Garcia-Garcia HM, Serruys PW; investigators of ABSORB Cohort A, B and EXTEND trials. Suwannasom P, et al. JACC Cardiovasc Interv. 2015 Jul;8(8):1130-1132. doi: 10.1016/j.jcin.2015.04.010. JACC Cardiovasc Interv. 2015. PMID: 26205450 Free article. No abstract available.
Impact of the Orbital Atherectomy System on a Peripheral Calcified Lesion: Quantitative Analysis by Intravascular Echogenicity.
Sotomi Y, Shammas NW, Suwannasom P, Campos CM, Wykrzykowska JJ, de Winter RJ, Dijkstra J, Serruys PW, Onuma Y. Sotomi Y, et al. Among authors: suwannasom p. JACC Cardiovasc Interv. 2015 Oct;8(12):e205-6. doi: 10.1016/j.jcin.2015.06.021. Epub 2015 Sep 17. JACC Cardiovasc Interv. 2015. PMID: 26386765 Free article. No abstract available.
Comparative analysis method of permanent metallic stents (XIENCE) and bioresorbable poly-L-lactic (PLLA) scaffolds (Absorb) on optical coherence tomography at baseline and follow-up.
Nakatani S, Sotomi Y, Ishibashi Y, Grundeken MJ, Tateishi H, Tenekecioglu E, Zeng Y, Suwannasom P, Regar E, Radu MD, Räber L, Bezerra H, Costa MA, Fitzgerald P, Prati F, Costa RA, Dijkstra J, Kimura T, Kozuma K, Tanabe K, Akasaka T, Di Mario C, Serruys PW, Onuma Y. Nakatani S, et al. Among authors: suwannasom p. EuroIntervention. 2016 Dec 20;12(12):1498-1509. doi: 10.4244/EIJY15M10_03. EuroIntervention. 2016. PMID: 26448577 Free article.
59 results